Financials in USD. Standardized financial statements.
A compact view of how Acutus Medical, Inc. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|
| Revenue? | $20.16M | $7.16M | $3.03M | $17.26M | $8.46M | $2.84M | $2.17M |
| Revenue Growth? | +181.4% | +136.4% | -82.4% | +104.0% | +198.4% | +30.9% | 0.0% |
| Cost of Revenue? | $19.14M | $10.30M | $31.91M | $32.92M | $15.89M | $9.24M | $7.51M |
| Gross Profit? | $1.01M | -$3.14M | -$1.91M | -$15.66M | -$7.42M | -$6.41M | -$5.34M |
| Gross Margin? | +5.0% | -43.8% | -63.0% | -90.7% | -87.7% | -225.9% | -246.7% |
| Operating Expenses? | $1.07M | $11.22M | $21.06M | $96.46M | $83.81M | $64.88M | $32.41M |
| Operating Income? | -$57,000 | -$14.36M | -$22.97M | -$115.87M | -$91.33M | -$72.57M | -$37.75M |
| EBITDA? | $2.25M | -$5.33M | $35.20M | -$105.12M | -$92.55M | -$71.60M | -$40.55M |
| Income Before Tax | -$4.54M | -$11.86M | $28.85M | -$117.68M | -$101.96M | -$97.04M | -$47.91M |
| Income Tax Expense | $0 | $63,000 | $15,000 | $0 | $23,000 | $0 | $0 |
| Net Income? | -$9.55M | -$81.66M | -$39.62M | -$117.68M | -$101.98M | -$97.04M | -$47.91M |
| EPS? | $-0.32 | $-2.81 | $-1.39 | $-4.11 | $-8.94 | $-3.54 | $-1.75 |
| Diluted EPS? | $-0.32 | $-2.81 | $-1.39 | $-4.11 | $-8.94 | $-3.54 | $-1.75 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality